DK142750C - Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive dopaminderivater eller syreadditionssalte deraf - Google Patents

Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive dopaminderivater eller syreadditionssalte deraf

Info

Publication number: DK142750C
Authority: DK; Denmark
Prior art keywords: racemic; analogue; preparation; acid addition; addition salts
Prior art date: 1972-04-12

Application number

DK196773A

Other languages

Danish (da)

English (en)

Other versions

DK142750B (da

Inventor

R R Tuttle

J Mills

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1972-04-12

Filing date

1973-04-11

Publication date

1981-08-17

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK142750(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1973-04-11 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

1978-11-27 Priority to DK527178A priority Critical patent/DK142076B/da

1981-01-12 Publication of DK142750B publication Critical patent/DK142750B/da

1981-08-17 Application granted granted Critical

1981-08-17 Publication of DK142750C publication Critical patent/DK142750C/da

Links

239000002253 acid Substances 0.000 title 1
VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical class NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 title 1
150000003839 salts Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/46—Friedel-Crafts reactions

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Cardiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Heart & Thoracic Surgery (AREA)
General Chemical & Material Sciences (AREA)
Hospice & Palliative Care (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK196773A 1972-04-12 1973-04-11 Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive dopaminderivater eller syreadditionssalte deraf DK142750C (da)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
DK527178A DK142076B (da)	1972-04-12	1978-11-27	Sekundære 3,4-dimethoxyphenethylamin-forbindelser til anvendelse som mellemprodukter ved fremstilling af dopaminderivater.

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US24346672A	1972-04-12	1972-04-12
US24346672		1972-04-12

Publications (2)

Publication Number	Publication Date
DK142750B DK142750B (da)	1981-01-12
DK142750C true DK142750C (da)	1981-08-17

Family

ID=22918877

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK196773A DK142750C (da)	1972-04-12	1973-04-11	Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive dopaminderivater eller syreadditionssalte deraf

Country Status (31)

Country	Link
JP (2)	JPS5825656B2 (fr)
KR (1)	KR790000113B1 (fr)
AR (1)	AR203822A1 (fr)
AT (1)	AT323719B (fr)
AU (1)	AU472734B2 (fr)
BE (1)	BE798051A (fr)
BG (1)	BG23001A3 (fr)
CA (1)	CA1018188A (fr)
CH (2)	CH569691A5 (fr)
CS (2)	CS190406B2 (fr)
CY (1)	CY963A (fr)
DD (1)	DD107670B3 (fr)
DE (1)	DE2317710C2 (fr)
DK (1)	DK142750C (fr)
ES (1)	ES413639A1 (fr)
FR (1)	FR2182947B1 (fr)
GB (1)	GB1392674A (fr)
HK (1)	HK50178A (fr)
HU (2)	HU167597B (fr)
IE (1)	IE37511B1 (fr)
IL (1)	IL42016A (fr)
KE (1)	KE2870A (fr)
MY (1)	MY7800381A (fr)
NL (1)	NL174459C (fr)
PH (1)	PH11041A (fr)
PL (2)	PL90695B1 (fr)
RO (2)	RO65105A (fr)
SE (1)	SE399064B (fr)
SU (1)	SU496719A3 (fr)
YU (2)	YU36483B (fr)
ZA (1)	ZA732136B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH585693A5 (fr) *	1974-02-08	1977-03-15	Ciba Geigy Ag
US4342692A (en) *	1980-10-20	1982-08-03	Usv Pharmaceutical Corporation	Pyrrolidines
ZA825227B (en) *	1981-07-22	1984-03-28	Syntex Inc	Substituted pyrrolidine cardiovascular system regulators antihypertensives
JPS6061523A (ja) *	1983-09-16	1985-04-09	Shionogi & Co Ltd	経口用ドブタミン製剤
ZA881076B (en) *	1987-02-24	1989-10-25	Lilly Co Eli	Dobutamine salts
JPH0383364U (fr) *	1989-12-18	1991-08-23
AU658188B2 (en) *	1991-05-20	1995-04-06	Tsumura & Co.	Phellodendrine analogs and allergy type IV suppressor containing the same as active ingredient
ATE155125T1 (de) *	1993-04-13	1997-07-15	Duphar Int Res	Herstellung von dobutamin verbindungen
EP0620208B1 (fr) *	1993-04-13	1997-07-09	Duphar International Research B.V	Production de composés de la dobutamine
WO2004031129A2 (fr)	2002-10-03	2004-04-15	New Era Biotech, Ltd.	Nouveaux composes destines au traitement des maladies auto-immunes, des maladies immuno-allergiques et des rejets en cas de greffes d'organes ou de tissus
CA2560922C (fr)	2004-03-26	2014-01-07	New Era Biotech, Ltd.	Ameliorations apportees a des composes destines a etre utilises dans le traitement du sida ou d'autres maladies virales et infections associees au vih et compositions contenant ces composes, methodes de traitement de ces maladies et de ces infections et methodes de fabrication de ces composes et de ces compositions
GB0804213D0 (en)	2008-03-06	2008-04-16	New Era Biotech Ltd	A method of printing or preventing pain
US9192585B2 (en)	2009-07-31	2015-11-24	Cognition Therapeutics, Inc.	Inhibitors of cognitive decline
US8802734B2 (en)	2009-09-09	2014-08-12	Novaremed Limited	Method of treating or preventing pain
EP2747759A4 (fr) *	2011-08-25	2015-05-13	Cognition Therapeutics Inc	Compositions et méthodes pour le traitement de maladies neurodégénératives
AU2015210852B2 (en)	2014-01-31	2019-01-24	Cognition Therapeutics, Inc.	Isoindoline compositions and methods for treating neurodegenerative disease
DK3634394T3 (da)	2017-05-15	2026-03-02	Cognition Therapeutics Inc	Sammensætninger til behandling af neurogenerative sygdomme
CN114524734B (zh) *	2021-12-27	2024-04-26	嘉实（湖南）医药科技有限公司	一种盐酸多巴酚丁胺的制备方法
CN117326958B (zh) *	2023-09-21	2025-07-11	锦州奥鸿药业有限责任公司	一种高纯度盐酸多巴酚丁胺的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2276619A (en) *		1942-03-17		N-phentlaliphatic-dihtoroxyphentnl

1973
- 1973-03-28 ZA ZA732136A patent/ZA732136B/xx unknown
- 1973-04-09 GB GB1683573A patent/GB1392674A/en not_active Expired
- 1973-04-09 CY CY963A patent/CY963A/xx unknown
- 1973-04-09 DE DE2317710A patent/DE2317710C2/de not_active Expired
- 1973-04-10 FR FR7312845A patent/FR2182947B1/fr not_active Expired
- 1973-04-10 SE SE7305032A patent/SE399064B/xx unknown
- 1973-04-10 IE IE563/73A patent/IE37511B1/xx unknown
- 1973-04-11 SU SU1908277A patent/SU496719A3/ru active
- 1973-04-11 KR KR7300573A patent/KR790000113B1/ko not_active Expired
- 1973-04-11 AT AT318773A patent/AT323719B/de not_active IP Right Cessation
- 1973-04-11 DK DK196773A patent/DK142750C/da not_active IP Right Cessation
- 1973-04-11 CA CA168,428A patent/CA1018188A/en not_active Expired
- 1973-04-11 CH CH517473A patent/CH569691A5/xx not_active IP Right Cessation
- 1973-04-11 CH CH1112475A patent/CH580563A5/xx not_active IP Right Cessation
- 1973-04-11 BE BE1004956A patent/BE798051A/fr not_active IP Right Cessation
- 1973-04-11 AU AU54385/73A patent/AU472734B2/en not_active Expired
- 1973-04-11 YU YU00976/73A patent/YU36483B/xx unknown
- 1973-04-11 NL NLAANVRAGE7305097,A patent/NL174459C/xx not_active IP Right Cessation
- 1973-04-11 BG BG023268A patent/BG23001A3/xx unknown
- 1973-04-12 CS CS732601A patent/CS190406B2/cs unknown
- 1973-04-12 RO RO7374457A patent/RO65105A/fr unknown
- 1973-04-12 HU HUEI552A patent/HU167597B/hu unknown
- 1973-04-12 CS CS77171A patent/CS190448B2/cs unknown
- 1973-04-12 HU HUEI469A patent/HU166213B/hu unknown
- 1973-04-12 PL PL1973161874A patent/PL90695B1/pl unknown
- 1973-04-12 ES ES413639A patent/ES413639A1/es not_active Expired
- 1973-04-12 AR AR247523A patent/AR203822A1/es active
- 1973-04-12 IL IL42016A patent/IL42016A/en unknown
- 1973-04-12 DD DD73170118A patent/DD107670B3/de unknown
- 1973-04-12 RO RO7383749A patent/RO70892A/fr unknown
- 1973-04-12 PH PH14508A patent/PH11041A/en unknown
- 1973-04-12 PL PL1973183808A patent/PL94207B1/pl unknown
- 1973-04-12 JP JP48041750A patent/JPS5825656B2/ja not_active Expired
1978
- 1978-08-10 KE KE2870A patent/KE2870A/xx unknown
- 1978-09-07 HK HK501/78A patent/HK50178A/xx unknown
- 1978-12-30 MY MY381/78A patent/MY7800381A/xx unknown
1979
- 1979-12-28 YU YU3212/79A patent/YU37113B/xx unknown
1982
- 1982-08-27 JP JP57149025A patent/JPS58131945A/ja active Granted

Also Published As

Publication number	Publication date
NL174459C (nl)	1984-06-18
CA1018188A (en)	1977-09-27
PH11041A (en)	1977-10-25
BE798051A (fr)	1973-10-11
AT323719B (de)	1975-07-25
JPS497237A (fr)	1974-01-22
AU5438573A (en)	1974-10-17
IE37511B1 (en)	1977-08-03
JPS58131945A (ja)	1983-08-06
YU36483B (en)	1984-02-29
KR790000113B1 (en)	1979-03-20
HU167597B (fr)	1975-11-28
HK50178A (en)	1978-09-15
RO65105A (fr)	1980-01-15
DD107670B3 (de)	1988-04-06
CS190406B2 (en)	1979-05-31
MY7800381A (en)	1978-12-31
IL42016A (en)	1976-05-31
CH580563A5 (fr)	1976-10-15
CY963A (en)	1978-12-22
YU321279A (en)	1983-04-27
GB1392674A (en)	1975-04-30
HU166213B (fr)	1975-02-28
DK142750B (da)	1981-01-12
JPS6221343B2 (fr)	1987-05-12
NL7305097A (fr)	1973-10-16
ZA732136B (en)	1974-03-27
JPS5825656B2 (ja)	1983-05-28
RO70892A (fr)	1982-02-26
NL174459B (nl)	1984-01-16
AR203822A1 (es)	1975-10-31
ES413639A1 (es)	1976-01-16
CH569691A5 (fr)	1975-11-28
DE2317710C2 (de)	1983-08-04
KE2870A (en)	1978-09-01
DE2317710A1 (de)	1973-10-18
PL90695B1 (fr)	1977-01-31
YU37113B (en)	1984-08-31
BG23001A3 (bg)	1977-05-20
FR2182947A1 (fr)	1973-12-14
CS190448B2 (en)	1979-05-31
IL42016A0 (en)	1973-06-29
YU97673A (en)	1982-02-25
DD107670A5 (de)	1974-08-12
SU496719A3 (ru)	1975-12-25
SE399064B (sv)	1978-01-30
FR2182947B1 (fr)	1976-07-02
AU472734B2 (en)	1976-06-03
PL94207B1 (fr)	1977-07-30

Similar Documents

Publication	Publication Date	Title
DK136714B (da)	1977-11-14	Analogifremgangsmåde til fremstilling af substituerede piperidinderivater eller syreadditionssalte deraf.
DK136904B (da)	1977-12-12	Analogifremgangsmade til fremstilling af racemiske eller optisk aktive 2-(heteroarylmethyl)-5,9beta-dialkyl-6,7-benzomorphaner eller syreadditionssalte deraf
DK138602B (da)	1978-10-02	Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive penicilliner eller salte deraf.
DK136527B (da)	1977-10-24	Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive p-alkoxyfenoxypropanolaminer eller syreadditionssalte deraf.
DK140281B (da)	1979-07-23	Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-cycloalkylaminopropaner eller syreadditionssalte heraf.
DK137234B (da)	1978-02-06	Analogifremgangsmåde til fremstilling af racemisk eller optisk aktiv 1-isopropylamino-3-(4-(2-isopropylkarbamoylaminoætyl)-fenoxy)-propanol-2 eller syreadditionssalte deraf.
DK147318C (da)	1984-12-24	Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive c-(2-benzofuranyl)-tetrahydropyridiner eller -piperidiner eller syreadditionssalte deraf
DK124081B (da)	1972-09-11	Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive piperazinderivater eller syreadditionssalte deraf.
DK145574C (da)	1983-05-30	Analogifremgangsmaade til fremstilling af substituerede cyclopropylalkylaminer eller syreadditionssalte deraf
DK141875C (da)	1980-11-17	Analogifremgangsmaade til fremstilling af normorphinonderivater eller syreadditionssalte deraf
DK126644B (da)	1973-08-06	Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive hydroxycrotonsyrer eller salte deraf med uorganiske eller organiske baser.
DK125639B (da)	1973-03-19	Analogifremgangsmåde til fremstilling af racemisk eller optisk aktivt 1-(2-nitrilophenoxy)-2-hydroxy-3-ethylaminopropan eller syreadditionssalte heraf.
DK140833B (da)	1979-11-26	Analogifremgangsmåde til fremstilling af phenylethylaminderivater eller syreadditionssalte deraf.
DK138491B (da)	1978-09-18	Analogifremgangsmåde til fremstilling af N-(1-cyclohexyl-3-pyrrolidinyl)-benzamider eller syreadditionssalte deraf.
DK139582B (da)	1979-03-12	Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive benzocycloheptaisoquinolin-forbindelser eller syreadditionssalte deraf.
DK129235B (da)	1974-09-16	Fremgangsmåde til fremstilling af racemiske eller optisk aktive quinolinderivater eller syreadditionssalte deraf.
DK133980C (da)	1977-01-31	Analogifremgangsmade til fremstilling af racemiske eller optisk aktive diphenylalkyllactamimidderivater eller syreadditionssalte deraf
DK133048C (da)	1976-08-16	Fremgangsmade til fremstilling af racemisk eller optisk aktiv 13beta-etyl-17alfa-etynyl-gon-4-en-3-on-17beta-ol
DK136722B (da)	1977-11-14	Analogifremgangsmåde til fremstilling af oxazolidinon-(2)-derivater eller syreadditionssalte heraf.
DK130958B (da)	1975-05-12	Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-hydroxyalkylaminopropaner eller fysiologisk tålelige syreadditionssalte heraf.
DK145576C (da)	1983-06-13	Analogifremgangsmaade til fremstilling af 6-fluor-substituerede thioxanthener eller syreadditionssalte deraf
DK138988B (da)	1978-11-27	Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive morphinanderivater.
DK136823B (da)	1977-11-28	Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive derivater af imidazo(2,1-b)thiazol eller syreadditionssalte deraf.
DK138117B (da)	1978-07-17	Analogifremgangsmåde til fremstilling af isoindolinderivater eller syreadditionssalte deraf.
DK133555C (da)	1976-10-25	Analogifremgangsmade til fremstilling af racemiske eller optisk aktive n-thienylmethyl-heterocycliske forbindelser eller syreadditionssalte deraf

Legal Events

Date	Code	Title	Description
1993-05-24	PUP	Patent expired